NSRX Nasus Pharma Ltd.
Company Analysis
Latest News
🟢 Nasus Pharma is trading 12% up today after first NS003 patient enrolled and dosed
Nasus Pharma is trading 12.04% higher at $4.00 after announcing the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29,...
🟢 Nasus Pharma is trading 11% up in pre-market after first NS003 patient enrolled and dosed
Nasus Pharma is trading at $3.95, up 10.64% in pre-market after the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29,...
Nasus Pharma Starts First Human Trial for a Nasal Anti-Nausea Drug — But Can a $20 Million Company Deliver on the Promise?
Shares of Nasus Pharma surged as much as 12.6% to $4.02 after the micro-cap Israeli drugmaker announced it had dosed the first patient in a Phase 1 clinical...
🟢 Nasus Pharma is trading 11.51% up in after-hours trading after first NS003 Phase 1 patient dosed
Nasus Pharma is trading at $4.02, up 11.51% in after-hours trading following its September 29 announcement that the first patient was enrolled and dosed in...
🟢 Nasus Pharma is trading 5.7% up in after-hours trading after NS003 Phase 1 dosing
Nasus Pharma is trading 5.69% up at $3.81 after hours, following the announcement that the first patient was enrolled and dosed in its NS003 Phase 1 study. -...
🟢 Nasus Pharma is trading 5.6% up today after first patient dosing in Phase 1 NS003
Nasus Pharma is trading at $3.79 (+5.57%) after announcing the first patient was enrolled and dosed in its Phase 1 NS003 study. - Announced September 29, 2026,...
🟢 Nasus Pharma is trading 5% up
Nasus Pharma is trading 5.01% up at $3.65, with no new company-specific announcement explaining the September 28 move found in available search results. - The...
🔴 Nasus Pharma is trading 8% down today as 10-year Treasury yield hits 19-year high
Nasus Pharma is trading at $3.35, down 7.97%, amid broader risk-off pressure, though the sharper decline’s trigger remains unclear. - No reliable Nasus...
🟢 Nasus Pharma is trading 6.16% up today with no identified company-specific catalyst
Nasus Pharma is trading 6.16% higher at $3.79, with no reliable company-specific announcement identified to explain the gain. - No reliable announcement dated...
🟢 Nasus Pharma is trading 5% up today
Nasus Pharma is trading 5.23% up now at $3.62, with today’s gain more consistent with trading activity than a newly reported event. - No reliable...
🔴 Nasus Pharma is trading 5% down today
Nasus Pharma is trading at $3.35, down -5.10%, with no reliable catalyst currently explaining the decline. - No company-specific headlines were reported for...
🔴 Nasus Pharma is trading 5% down today
Nasus Pharma is trading 5.01% down now at $3.41, with no confirmed company-specific catalyst identified for the decline. - No new company-specific...
🔴 Nasus Pharma is trading 5.47% down today as Treasury yields reach a 19-year high
Nasus Pharma is trading at $3.45 (-5.47%) amid broad market pressure. • Broader markets are under pressure as Treasury yields reach a 19-year high and oil...
🟢 Nasus Pharma is trading 10.14% up today after FDA clearance for NS002 IND
Nasus Pharma is trading at $3.75, up +10.14% on September 14, 2026, after the FDA cleared its IND application for NS002, an investigational intranasal...
Nasus Pharma Gets the FDA Green Light for a Needle-Free EpiPen Rival — But Can a $62 Million Company Crack a Multibillion-Dollar Market?
Shares of Nasus Pharma jumped 8.4% to $3.69 Monday morning after the company announced the FDA cleared its application to begin a pivotal clinical trial of an...
🟢 Nasus Pharma is trading 8.1% up today after FDA clearance of NS002 IND
Nasus Pharma is trading 8.1% up at $3.68 after the FDA cleared its IND application for NS002, an investigational intranasal epinephrine powder for...
🟢 Nasus Pharma is trading 8.4% up today after FDA clearance for its NS002 IND application
Nasus Pharma is trading 8.4% higher at $3.69 after the U.S. FDA cleared its Investigational New Drug (IND) application for NS002, an intranasal epinephrine...
🔴 Nasus Pharma is trading 7% down today after hotter-than-expected August PPI
Nasus Pharma is trading at $3.30, down -7.04%, as broader risk-off sentiment intensified on September 10, 2026. • U.S. stocks weakened after August PPI rose...
🔴 Nasus Pharma is trading 11.34% down today as healthcare and broader markets come under pressure
Nasus Pharma is trading 11.34% down at $3.44, primarily as healthcare and broader markets come under pressure. - The decline reverses the September 8...
🟢 Nasus Pharma is trading 6.37% up today after announcing its H.C. Wainwright conference presentation
Nasus Pharma is trading $3.97 (+6.37%) after announcing management’s presentation at the H.C. Wainwright 28th Annual Global Investment Conference. - The...